Correlation Between Nexien Biopharma and Cann American

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nexien Biopharma and Cann American at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nexien Biopharma and Cann American into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nexien Biopharma and Cann American Corp, you can compare the effects of market volatilities on Nexien Biopharma and Cann American and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nexien Biopharma with a short position of Cann American. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nexien Biopharma and Cann American.

Diversification Opportunities for Nexien Biopharma and Cann American

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Nexien and Cann is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Nexien Biopharma and Cann American Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cann American Corp and Nexien Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nexien Biopharma are associated (or correlated) with Cann American. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cann American Corp has no effect on the direction of Nexien Biopharma i.e., Nexien Biopharma and Cann American go up and down completely randomly.

Pair Corralation between Nexien Biopharma and Cann American

Given the investment horizon of 90 days Nexien Biopharma is expected to generate 2.66 times more return on investment than Cann American. However, Nexien Biopharma is 2.66 times more volatile than Cann American Corp. It trades about 0.15 of its potential returns per unit of risk. Cann American Corp is currently generating about 0.01 per unit of risk. If you would invest  1.70  in Nexien Biopharma on September 6, 2024 and sell it today you would earn a total of  0.30  from holding Nexien Biopharma or generate 17.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.44%
ValuesDaily Returns

Nexien Biopharma  vs.  Cann American Corp

 Performance 
       Timeline  
Nexien Biopharma 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Nexien Biopharma are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Nexien Biopharma displayed solid returns over the last few months and may actually be approaching a breakup point.
Cann American Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cann American Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat fragile basic indicators, Cann American may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Nexien Biopharma and Cann American Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nexien Biopharma and Cann American

The main advantage of trading using opposite Nexien Biopharma and Cann American positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nexien Biopharma position performs unexpectedly, Cann American can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cann American will offset losses from the drop in Cann American's long position.
The idea behind Nexien Biopharma and Cann American Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stocks Directory
Find actively traded stocks across global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios